Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.60%
1,062.40
+6.32
+0.60%
—1,056.081,055.451,067.221,044.14——
SIXC
Communications
SIXC
Communications
SIXC
-0.03%
606.74
-0.16
-0.03%
—606.90606.90610.73601.25——
SIXE
Energy
SIXE
Energy
SIXE
-1.08%
1,238.21
-13.50
-1.08%
—1,251.711,264.021,267.841,229.38——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.12%
1,718.61
-2.03
-0.12%
—1,720.641,717.521,726.381,702.65——
SIXM
Financials
SIXM
Financials
SIXM
+0.21%
637.37
+1.36
+0.21%
—636.01635.43638.14630.76——
SIXR
Staples
SIXR
Staples
SIXR
-0.96%
853.59
-8.29
-0.96%
—861.88854.93854.93841.82——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.33
+0.25
+0.11%
—218.08218.08218.46215.77——
SIXT
Technology
SIXT
Technology
SIXT
+0.78%
3,594.81
+27.84
+0.78%
—3,566.973,549.543,603.173,543.40——
SIXU
Utilities
SIXU
Utilities
SIXU
+1.03%
908.54
+9.27
+1.03%
—899.27900.59908.91897.62——
SIXV
Health care
SIXV
Health care
SIXV
+0.64%
1,495.00
+9.53
+0.64%
—1,485.471,483.471,496.661,472.99——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.64%
2,398.31
+15.25
+0.64%
—2,383.062,381.252,408.622,360.53——
LRMR:NASDAQ
Larimar Therapeutics Inc
$3.57
+1.13%
(+0.040) 1D
$3.57
+0.09% (+0.0031)
After hours
Closed: May 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LRMR...
Open
$3.45
High
$3.58
Low
$3.40
Mkt. cap
370.86M
Avg. vol.
1.65M
Volume
0.00
52-wk high
$6.42
52-wk low
$1.80
EPS
-$2.08
Beta
0.91
Shares outstanding
103.88M
No. of employees
71
News stories
From sources across the web
About Larimar Therapeutics Inc
CEO-
Employees71
Founded2005
HeadquartersBala Cynwyd, Pennsylvania, United States
SectorBiotechnology
Websitelarimartx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.27M
44.83M
59.17M
24.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.52M
4.67M
4.84M
6.19M
Operating expense
27.79M
49.50M
64.02M
31.12M
Total operating expenses
27.79M
49.50M
64.02M
31.12M
Operating income
-27.79M
-49.50M
-64.02M
-31.12M
Other non operating income
1.61M
1.79M
1.52M
1.50M
EBT including unusual items
-26.18M
-47.71M
-62.50M
-29.61M
EBT excluding unusual items
-26.18M
-47.71M
-62.50M
-29.61M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.18M
-47.71M
-62.50M
-29.61M
Net profit margin
-
-
-
-
Earnings per share
-0.41
-0.61
-0.73
-0.31
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.70M
-49.41M
-63.93M
-31.05M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer